ZSCAN18 methylation is prevalent and negatively correlated with expression in multiple human cancers, and the potential of ZSCAN18 methylation as a marker for tumor diagnosis and prognosis has been discovered. This evidence concerns the gene ZSCAN18 and neoplasm.